The NCD epidemic is the dominant burden.
650 NCD deaths per 100,000 people, nearly three times the global rate of 240. 19% of all Qatari deaths trace back to diabetes alone.


NHS 2024–2030 and Qatar National Vision 2030 name the destination. The route from policy to a working prototype is what NABD builds.
90% of health innovations fail before they reach a user. 80–95% of health AI never reaches scale. NABD is the pipeline that closes the gap.
Ten problems came up repeatedly in scoping conversations with MOPH, HMC, and PHCC. None are new. The cost of leaving them unsolved keeps climbing. Scroll.
650 NCD deaths per 100,000 people, nearly three times the global rate of 240. 19% of all Qatari deaths trace back to diabetes alone.
HMC carries a 35% vacancy rate. Each physician sees about 1,200 patients, twice what's considered sustainable.
Specialty appointments take six to twelve months. 73% of patients can't get an emergency slot when they need one.
69% of primary-care-appropriate visits land in specialty hospitals. Only 31% of patients use PHCC services as designed.
PDPL Law 13/2016 requires it. Most international AI tools don't comply because they don't store data locally.
Only 44% of healthcare institutions evaluate AI tools for bias before deploying them. We train ten clinicians per cohort.
Up to two hours of every physician's day. Zero local AI scribes support Arabic medical documentation.
2–30% across outpatient. Up to 60% in mental health, the highest of any specialty. Each missed slot costs QAR 350–500.
Qatar's National Development Strategy 3 says so in those words. There is no defined route from idea to MOPH adoption.
Longest waits. Highest no-shows. Most stigma. Care is fragmented across PHCCs, HMC, and private providers, and the handoffs are weak.
The evidence sits in named places: NHS Innovation Accelerator, Cleveland Clinic Innovations, the STARS study, the AACN cycle. Two decades of public data, no assertion required.
Problem validation. Stakeholder mapping at MOPH, HMC, and PHCC. Clinical-need confirmation.
Solution design. Value proposition. Target users. Impact metrics. First wireframes.
No-code prototype development. Weekly mentor sessions. User testing with clinical advisors. Four weeks. The one that decides everything.
Pilot design with MOPH. Investor-ready deck. Demo Day rehearsal. December 2026 / MOPH leadership in the room.
Clinicians, founders, and operators who walk every team through the twelve weeks. Weekly reviews. Design clinics. Direct access from week one.














Fourteen seats for Qatar-based clinicians, researchers, technologists, and founders. Twelve weeks. No equity. The seat is yours to keep building from after Demo Day.
Nationality is not a filter.
Clinicians, researchers, technologists, founders. Teams or solos.
Working prototype welcome but not required.
Weekly mentor reviews, in person at QSTP and online.
Applications open July 2026. Get notified the day they go live.
Twelve weeks. Fourteen seats. The pulse of Qatar's health innovators.